Peoples Bancorp (PEBO)
(Real Time Quote from BATS)
$30.31 USD
-0.09 (-0.30%)
Updated May 14, 2024 01:12 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Income Statements
Fiscal Year end for Peoples Bancorp Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 527 | 348 | 254 | 221 | 234 |
Cost Of Goods | 72 | 9 | 10 | 14 | 22 |
Gross Profit | 455 | 339 | 244 | 207 | 212 |
Selling & Adminstrative & Depr. & Amort Expenses | 282 | 204 | 184 | 160 | 140 |
Income After Depreciation & Amortization | 173 | 136 | 59 | 47 | 72 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 28 | 7 | 2 | 5 | 7 |
Pretax Income | 145 | 129 | 57 | 43 | 65 |
Income Taxes | 32 | 27 | 9 | 8 | 12 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 113 | 101 | 48 | 35 | 54 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 113 | 101 | 48 | 35 | 54 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 177 | 153 | 84 | 73 | 90 |
Depreciation & Amortization (Cash Flow) | 4 | 17 | 25 | 26 | 18 |
Income After Depreciation & Amortization | 173 | 136 | 59 | 47 | 72 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 32.76 | 28.00 | 21.96 | 19.84 | 20.27 |
Diluted EPS Before Non-Recurring Items | 4.03 | 3.71 | 3.03 | 1.95 | 2.93 |
Diluted Net EPS (GAAP) | 3.44 | 3.60 | 2.15 | 1.73 | 2.63 |
Fiscal Year end for Peoples Bancorp Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 153.37 | 149.38 | 146.80 | 127.43 | 103.21 |
Cost Of Goods | 33.30 | 29.60 | 22.48 | 14.40 | 5.66 |
Gross Profit | 120.07 | 119.78 | 124.32 | 113.03 | 97.55 |
SG&A, R&D, and Dept/Amort Expenses | 74.57 | 68.97 | 75.75 | 78.61 | 58.33 |
Income After SG&A, R&D, and Dept/Amort Expenses | 45.50 | 50.81 | 48.57 | 34.42 | 39.22 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 7.65 | 7.27 | 7.84 | 7.16 | 5.61 |
Pretax Income | 37.85 | 43.53 | 40.73 | 27.26 | 33.61 |
Income Taxes | 8.27 | 9.70 | 8.85 | 6.17 | 7.05 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 29.58 | 33.83 | 31.88 | 21.10 | 26.56 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 29.58 | 33.83 | 31.88 | 21.10 | 26.56 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 35.05 | 35.09 | 35.06 | 32.65 | 27.40 |
Diluted EPS Before Non-Recurring Items | 0.85 | 1.04 | 1.06 | 0.83 | 1.01 |
Diluted Net EPS (GAAP) | 0.84 | 0.96 | 0.90 | 0.64 | 0.94 |